246683 Eliminating Tobacco Disparities through Community-based Participatory Research and Outreach

Tuesday, November 1, 2011

Elisa Tong, MD , Division of General Internal Medicine, Department of Medicine, University of California, Davis, Sacramento, CA
Leslie Cooper, PhD, MPH, BSN, RN , Division of Research Infrastructure, National Center for Research Resources, Bethesda, MD
William Carroll, MD , Surgery - Otolaryngology, University of Alabama at Birmingham, Birmingham, AL
Pebbles Fagan, PhD, MPH , Tobacco Control Research Branch, BRP, DCCPS, National Cancer Institute, Bethesda, MD
John Foster-Bey, MPA, MBA , Evaluation Research, CSR, Incorporated, Arlington, VA
James R. Hebert, ScD , Cancer Prevention and Control Program, University of South Carolina, Columbia, SC
Maria Lopez-Class, PhD, MPH, MS , Cancer Control Program, Georgetown University, Washington, DC
Grace X. Ma, PhD , Center for Asian Health, Department of Public Health, Temple University, Philadelphia, PA
Eliseo J. Perez-Stable, MD , Department of Internal Medicine, University of California, San Francisco, San Francisco, CA
Yin Tan, MD , Department of Public Health, Temple University, Center for Asian Health, Philadelphia, PA
Janice Y. Tsoh, PhD , Department of Psychiatry, UCSF, San Francisco, CA
BACKGROUND: From 2005-2010, National Cancer Institute funded 25 networks in its Community Networks Program (CNP), which aims to reduce cancer health disparities through community-based participatory education, training, and research among racial/ethnic and underserved populations. Although there was no mandate to address tobacco, we wanted to assess the extent the CNP networks and their local communities identified this key risk factor as a priority area and how they addressed it. METHODS: Using a framework that identifies 11 key scientific areas for research to eliminate tobacco-related health disparities, we reviewed the CNP contributions in each area. CNP investigators and their reports to the CNP national evaluator were queried. RESULTS: Almost all CNP networks (96%) have conducted tobacco-related activities. The CNP networks have published over 103 articles related to tobacco, which reflects the highest percent distribution (11.9%) of the CNP cancer-related publications. The key scientific areas CNP networks contributed towards most were surveillance, psychosocial research, and treatment of nicotine addiction. The CNP networks conducted 1147 tobacco-related cancer education activities. As part of the objective to develop new research and young investigators, there were 9 tobacco-related pilot projects, representing 15.5% of all CNP cancer-related pilot projects. CONCLUSION: The CNP is a promising model for engaging the community to eliminate tobacco-related health disparities. The diverse contributions by the CNP reflect the needs of various regions and communities in different stages of tobacco control. Future evaluation efforts should consider common core measures and a comprehensive strategy to evaluate progress and encourage collaboration across communities and groups.

Learning Areas:
Assessment of individual and community needs for health education
Conduct evaluation related to programs, research, and other areas of practice
Diversity and culture
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs

Learning Objectives:
1. Define the National Cancer Institute's Community Networks Program and aims 2. Describe the CNP networks' tobacco-related activities in research and outreach 3. Assess the CNP model potential for addressing tobacco-related health disparities

Keywords: Tobacco Control, Community-Based Partnership

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified because I am a tobacco control researcher and part of the Community Network Program network.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.